METFORMIN HCL
Product:
Pozemet
Description:
Pozemet tablet contains two oral antihyperglycemic drugs, pioglitazone hydrochloride and metformin hydrochloride. They are used in the management of type 2 diabetes.
Pioglitazone hydrochloride acts primarily by decreasing insulin resistance. It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. It reduces circulating insulin levels and improves glycemic control.
Metformin hydrochloride improves glucose tolerance by lowering both basal and postprandial plasma glucose. It improves insulin sensitivity by increasing peripheral glucose uptake and utilization. It also decreases hepatic glucose production and intestinal absorption of glucose.